Martin Shkreli, the reviled drug company CEO who faces federal criminal charges, nearly doubled his $3 million investment in KaloBios.
Business and financial news - CNNMoney.com, CNN: Business
Tue, 08/30/2016 - 11:26am
Martin Shkreli, the reviled drug company CEO who faces federal criminal charges, nearly doubled his $3 million investment in KaloBios.